The report of FDA-mandated prospective evaluation of outcomes after Cox Maze-IV for atrial fibrillation during cardiac surgery for other problems. It utilized the Synergy ablation system and focused on absence of AF off antiarrhythmics at 6 months and the absence of major adverse events at 30 days. 76% were AF free, and 9.1% experienced major complications. Results were comparable to the cut-and-sew technique of the Cox Maze-III procedure.
You are here:
The ABLATE Trial: Safety and Efficacy of Cox Maze-IV Using a Bipolar Radiofrequency Ablation System
Submitted by: Mark Ferguson
Source: Annals of Thoracic Surgery
Keywords:
Author(s): Jonathan M. Philpott, Christian W. Zemlin, James L. Cox, Mack Stirling, Michael Mack, Robert L. Hooker, Allen Morris, David A. Heimansohn, James Longoria, Divyakant B. Gandhi, Patrick M. McCarthy
